Keith Wycoff
Board Member @Seal Rock Therapeutics
Signup · Get unlimited contacts
WORK HISTORY
Board Member @Seal Rock Therapeutics
Seattle, WA, US
Seal Rock is developing a first-in-class NASH therapeutic.
EDUCATION
University of California, Davis
BS, MS, Botany
Harvard Kenneth C. Griffin Graduate School of Arts and Sciences
PhD, Cellular and Developmental Biology
SKILLS
ABOUT KEITH WYCOFF
An innovative research and development leader specializing in developing antibodies, receptor-Fc fusions and other recombinant proteins as human therapeutics using plant-based expression platforms. A highly effective rainmaker, capturing more than $25M in non-dilutive funding through government grants and contracts. A productive research partner, initiating and managing collaborations with academic and industrial scientists in a variety of disciplines.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.